CAR-T cells forge ahead, Novartis reorganizes.
Cormac
C
Sheridan
D055808:Drug Discovery; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D011946:Receptors, Antigen / Q000235:genetics* / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism*; D013601:T-Lymphocytes / Q000502:physiology*
D011946:Receptors, Antigen; D011994:Recombinant Proteins